List of New HCV/Hepaititis C Medicines

Time for New Cures – Time to list new hepatitis C prescriptions

It is uncommon that an administration has the ability to change the course of a pandemic however that is the notable

opportunity accessible to you and your partners.

Australia is at an intersection. Down one way lies heightening rates of liver illness and demise. Down the other,

there is a chance to make hepatitis C an uncommon condition in our lifetime.

The twenty-seven associations which are signatories to this letter recognize your dedication to

react to the needs of medicinal services purchasers and repay new treatments that treat conditions running

from growth to eye sickness. As being what is indicated, we ask you to assist value arrangements and affirm the expansion

of the new leap forward hepatitis C drugs on the Pharmaceutical Benefits Scheme immediately.

These new medications cure hepatitis C and speak to a life saver for some individuals. Yet in spite of being

suggested by the Pharmaceutical Benefits Advisory Committee six months prior, these prescriptions are

as yet anticipating thought by the Federal Cabinet.

With extraordinarily high cure rates, shorter treatment term and less reactions than existing treatments,

without interferon meds hold the way to counteracting liver cirrhosis, liver tumor and liver disappointment – not to

notice stopping the rising loss of life connected with untreated hepatitis C.

As you probably are aware, treatment rates remain heartbreakingly low. One and only per penny of the 230,500 Australians living with

hepatitis C are dealt with every year. This puts thousands at danger of advancing to genuine liver sickness.

Of further concern are reports by liver center staff that hepatitis C treatment rates have plunged again as

more individuals end up in a treatment limbo.

Tragically, Australia can no more respect itself the "fortunate nation"; not when individuals with hepatitis C are being

cured far and wide – from the United States and Great Britain to Egypt and India. Progressively,

frantic Australians are being compelled to travel abroad, or take the hazardous course of importing medications

since these new treatments stay excessively expensive in Australia.

Clergyman, it's the ideal opportunity for activity. It's the ideal opportunity for you to mediate and bring the Department, the pharmaceutical

organizations and the Cabinet together to convey the cures for which such a large number of Australians are urgently

holding up.

We beseech you to grasp another treatment time, to affirm a PBS posting date and make 2015 a watershed year in the battle against hepatitis C.